Human IgG antibody Laboratories manufactures the fusion peptide sequence and sars-cov reagents distributed by Genprice. The Fusion Peptide Sequence And Sars-Cov reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Peptide. Other Fusion products are available in stock. Specificity: Fusion Category: Peptide Group: Sequence And
SARS-CoV-2 (COVID-19) NSP6 Peptide |
|||
| 9177P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP6 Peptide |
|||
SARS-CoV-2 (COVID-19) NSP10 Peptide |
|||
| 9179P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) NSP10 Peptide |
|||
SARS-CoV-2 (COVID-19) ORF6 Peptide |
|||
| 9189P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF6 Peptide |
|||
SARS-CoV-2 (COVID-19) ORF9b Peptide |
|||
| 9191P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF9b Peptide |
|||
SARS-CoV-2 (COVID-19) ORF3a Peptide |
|||
| 9275P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF3a Peptide |
|||
SARS-CoV-2 (COVID-19) ORF3b Peptide |
|||
| 9277P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF3b Peptide |
|||
SARS-CoV-2 (COVID-19) ORF3b Peptide |
|||
| 9279P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF3b Peptide |
|||
SARS-CoV-2 (COVID-19) ORF3b Peptide |
|||
| 9281P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF3b Peptide |
|||
SARS-CoV-2 (COVID-19) ORF7a Peptide |
|||
| 9283P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF7a Peptide |
|||
SARS-CoV-2 (COVID-19) ORF7a Peptide |
|||
| 9285P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF7a Peptide |
|||
SARS-CoV-2 (COVID-19) ORF8 Peptide |
|||
| 9287P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF8 Peptide |
|||
SARS-CoV-2 (COVID-19) ORF8 Peptide |
|||
| 9289P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF8 Peptide |
|||
SARS-CoV-2 (COVID-19) ORF9c Peptide |
|||
| 9291P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF9c Peptide |
|||
SARS-CoV-2 (COVID-19) ORF10 Peptide |
|||
| 9293P | ProSci | 0.05 mg | EUR 235.5 |
|
Description: SARS-CoV-2 (COVID-19) ORF10 Peptide |
|||
SARS-CoV Spike Antibody |
|||
| 3219-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
SARS-CoV Spike Antibody |
|||
| 3219-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||
SARS-CoV Spike Antibody |
|||
| 3221-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
|||